020406080100Estimated vaccination coverage (%)8882396543563249Tdapd1 doseMenACWYe1 doseMenACWY2 dosesfHPVg1 dose, femalesHPV3 doses, femalesHPV1 dose, malesHPV3 doses, maleshVaccine80%Healthy People 2020 Goalsb70%Healthy People 2020 Influenza Goalc020406080100Estimated vaccination coverage (%)Tdapd1 doseMenACWYe1 doseMenACWY2 dosesfHPVg1 dose, femalesHPV3 doses, femalesHPV1 dose, malesHPV3 doses, maleshVaccine80%888239654356324970%Healthy People 2020 GoalsbHealthy People 2020 Influenza Goalc
For US Health Care Professionals Only

A consortium of health care providers from multiple disciplines collaborating to raise immunization rates
among older adolescents by establishing an immunization platform visit at 16 years of age.

Learn more about the rationale for the
platform visit.

View White Paper
Image of two hands in handshake


To improve vaccination rates among adolescents by collaborating with stakeholders in the health care community to establish an immunization platform at age 16 years, elevating the importance of this visit on the immunization schedule.

Image of a light bulb


We envision a national immunization platform whereby all adolescents in the United States are properly immunized against vaccine-preventable diseases.

Image of 3 intersecting circles

16-Year-Old Immunization Platform Visit

In the 2017 schedule, the Advisory Committee on Immunization Practices (ACIP) instituted
a change by carving out an immunization visit specifically for adolescents 16 years of age to highlight the need for improving immunization rates across a number of older adolescent
Click here to see the ACIP schedule.

Substantial Gaps Exist in Vaccination
Coverage Rates Among 13- to 17-Year-Olds

Immunization Rates in Adolescents 13-17 Years of Age1-3,a

aData are from 2016, except where noted. bHealthy People 2020 Goals are
for 80% of adolescents to have received 1 Tdap dose, 1 MenACWY dose,
and 3 HPV vaccine doses by age 13-15. cHealthy People 2020 Goal is for 70% of children 6 months to 17 years of age to have received an annual influenza vaccine. dTdap = Tetanus, diphtheria, and acellular pertussis vaccine. eMenACWY = Quadrivalent meningococcal conjugate vaccine (serogroups A, C, W, and Y). fSecond dose rate based on 17-year-olds. gHPV = Human papillomavirus vaccine. h2016-2017 influenza season.

Adapted from http://www.adolescentvaccination.org/resources/call-to-action-adolescent-vaccination-challenges.pdf on December 8, 2017, courtesy of the National Foundation for Infectious Diseases. Data updated for this website January 2018.

References: 1. Centers for Disease Control and Prevention (CDC). National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—
United States, 2016. MMWR. 2017:66(33);874-882. 2. CDC. Flu vaccination coverage, United States, 2016-17 influenza season. https://www.cdc.gov/flu/fluvaxview/coverage-1617
estimates.htm. Accessed January 23, 2018. 3. HealthyPeople.gov. Immunization and infectious diseases. https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives. Accessed January 23, 2018.

Organizations Working to Improve
Adolescent Immunization Rates